Patient Square Capital as of Dec. 31, 2024
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 20 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 55.2 | $148M | 13M | 11.83 | |
| Liquidia Corporation Com New (LQDA) | 8.2 | $22M | 1.9M | 11.76 | |
| Insmed Com Par $.01 (INSM) | 7.9 | $21M | 307k | 69.04 | |
| Cullinan Oncology (CGEM) | 4.0 | $11M | 879k | 12.18 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 3.9 | $11M | 1.4M | 7.45 | |
| Nurix Therapeutics (NRIX) | 3.1 | $8.4M | 446k | 18.84 | |
| Intra Cellular Therapies (ITCI) | 2.2 | $6.0M | 72k | 83.52 | |
| Enliven Therapeutics (ELVN) | 1.9 | $5.0M | 224k | 22.50 | |
| Geron Corporation (GERN) | 1.7 | $4.7M | 1.3M | 3.54 | |
| Ocular Therapeutix (OCUL) | 1.5 | $4.0M | 471k | 8.54 | |
| Agios Pharmaceuticals (AGIO) | 1.5 | $4.0M | 122k | 32.86 | |
| Pharvaris N V (PHVS) | 1.5 | $4.0M | 208k | 19.17 | |
| Disc Medicine (IRON) | 1.3 | $3.6M | 56k | 63.40 | |
| Springworks Therapeutics (SWTX) | 1.3 | $3.4M | 93k | 36.13 | |
| Allogene Therapeutics (ALLO) | 1.2 | $3.2M | 1.5M | 2.13 | |
| Mirum Pharmaceuticals (MIRM) | 1.0 | $2.7M | 65k | 41.35 | |
| Intellia Therapeutics (NTLA) | 0.9 | $2.5M | 216k | 11.66 | |
| Arvinas Ord (ARVN) | 0.6 | $1.7M | 87k | 19.17 | |
| Scholar Rock Hldg Corp (SRRK) | 0.5 | $1.4M | 32k | 43.22 | |
| Astria Therapeutics | 0.4 | $939k | 105k | 8.94 |
